Kato Masato, Satoh Daizoh, Okada Yoshifumi, Sugiyama Kimitoshi, Toda Noriko, Kurosawa Shin
Department of Anesthesiology and Perioperative Medicine, Tohoku University School of Medicine, Sendai 980-8575.
Masui. 2007 Nov;56(11):1281-6.
In this review, the authors tried to summarize the characteristics and main differences of remifentanil with other opioids, and to overview its pharmacodynamics and pharmacokinetics. Clearance and volume of distribution of remifentnail are extremely different from other conventional opioids. In addition, the context-sensitive half time of remifentanil is almost stable (about 3 minutes) even if the continuous infusion of remifentanil lasts for longer than 10 hours. As remifentanil is metabolized by a non-specific esterase, excretion of remifentnil is predictable in basically all patients undergoing general anesthesia and surgery. Therefore, remifentanil is considered to be an optimal opioid as an analgesic combined either with inhalational anesthetics or intravenous hypnotics in balanced general anesthesia.
在本综述中,作者试图总结瑞芬太尼与其他阿片类药物的特点及主要差异,并概述其药效学和药代动力学。瑞芬太尼的清除率和分布容积与其他传统阿片类药物截然不同。此外,即使瑞芬太尼持续输注超过10小时,其背景敏感半衰期几乎保持稳定(约3分钟)。由于瑞芬太尼由非特异性酯酶代谢,在基本上所有接受全身麻醉和手术的患者中,瑞芬太尼的排泄都是可预测的。因此,在平衡全身麻醉中,瑞芬太尼被认为是与吸入性麻醉药或静脉催眠药联合使用的最佳镇痛阿片类药物。